Pre-eclampsia and eclampsia (PE/E)—life-threatening high blood pressure and excess protein in the urine after 20 weeks gestation—is a leading cause of pregnancy-related deaths. These deaths are preventable, yet essential medicines and tools to treat this disorder are often unavailable in low-resource settings. The Population Council implemented a two-phase intervention involving training, mentoring, and supervising providers at secondary facilities on detection and management of PE/E patients (Phase 1), and training primary health care (PHC) providers to administer a modified loading dose of magnesium sulphate and refer women to secondary health facilities for monitoring (Phase 2). This brief describes the Population Council’s implementation research study to evaluate this task-shifting process around the prevention, detection, and management of PE/E at the PHC level. The study showed that not only were PHC providers effectively able to carry out this task, but maternal mortality in the intervention group decreased.
Warren, Charlotte E. 2018. "Ending Eclampsia: PHC PH/E_plus Model," Ending Eclampsia Research Brief. Washington, DC: Population Council.